logo
logo

The Rohatyn Group Completes Investment in European Contract Research Organization, Optimapharm

May 12, 2020over 5 years ago
New York

Description

The Rohatyn Group (“TRG”), an emerging markets focused asset management firm, today announced that it has completed an investment in Optimapharm d.d. (“Optimapharm” or the “Company”), to establish a partnership with the company’s founders Gordana Gregurić Čičak and Igor Čičak. Optimapharm is a contract research organization (“CRO”) managing clinical trials on behalf of leading biotech, pharma and medical devices companies in 22 countries throughout Europe.

Company Information

Company

The Rohatyn Group

Location

New York, New York, United States

About

Founded in 2002, The Rohatyn Group is an emerging markets focused asset management firm headquartered in New York, with offices around the globe including Boston, Singapore, Rotorua, Mumbai, New Delhi, London, Buenos Aires, Montevideo, Lima, and São Paulo. For more information, please visit www.rohatyngroup.com

Related People